Journals / Türk Jinekoloji ve Obstetrik Derneği Dergisi / 2012 / Cilt: 9 - Sayı: 3

Surgıcal management ın gestatıonal trophoblastıc dıseases

Gestasyonel trofoblastik hastalıklarda cerrahi yaklaşımlar

Pages
133–141
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review discusses the indications and the role of surgical interventions during the management of women with hydatidiform moles and malignant gestational trophoblastic neoplasia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Management of hydatidiform moles remains surgical evacuation and human gonadotropin monitoring.
📊
Key Findings & Data:Hysterectomy may be an option for patients especially who do not wish to preserve fertility.
💡
Conclusion & Impact:This review discusses the indications and the role of surgical interventions during the management of women with hydatidiform moles and malignant gestational trophoblastic neoplasia.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Management of hydatidiform moles remains surgical evacuation and human gonadotropin monitoring. Hysterectomy may be an option for patients especially who do not wish to preserve fertility. Althought chemotherapy regimes are very effective for treating malignant gestational throphoblastic neoplasia, hysterectomy and other extirpative procedures play an important role especially in reducing the amount of chemotherapy, drug-insensitive diseases and hemorrhagic complications. This review discusses the indications and the role of surgical interventions during the management of women with hydatidiform moles and malignant gestational trophoblastic neoplasia.

Özet

Hidatiform mol hastalarına yaklaşım cerrahi olarak uterusun boşaltılması ve human koryonik gonadotropin (hCG) izlemi şeklindedir. Histerektomi özellikle fertilitesini korumayı arzulamayan hastalarda bir tedavi seçeneğidir. Malign gestasyonel trofoblastik neoplazilerde kemoterapinin etkinliğine rağmen özellikle total kemotarapi dozunun azaltılmasında, ilaca direnç gelişen ve kanama gelişen vakalarda histerektomi ile ekstirpasyon yöntemleri tedavide önemli rol oynarlar. Bu derlemede hidatiform mol ve malign gestasyonel trofoblastik neoplazilerde cerrahinin rolü ve endikasyonları tartışılmıştır.

🔖

Cite This Article

ÖZALP, S. S., ÖGE, T. (2022). Surgıcal management ın gestatıonal trophoblastıc dıseases. Türk Jinekoloji ve Obstetrik Derneği Dergisi, Cilt: 9 - Sayı: 3, 133–141. https://ajindex.com/articles/631571

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Özalp S.: Gestasyonel trofoblastik tümörler, Klinikte Obstetrik ve Jinekoloji, Editörler, Çiçek N., Mungan T, Günefl Tıp Kitabevleri Ltd. fiti, Ankara, 2006, sf.797- 807. Özalp S.: Gestasyonel trofoblastik hastalıklar, Ed. Ayhan A., Durukan T., Günalp S., Gürgan T., Önderoğlu LS., Yaralı H., Yüce K.: Temel Kadın Hastalıkları ve Doğum Bilgisi, İkinci Baskı,
  2. Günefl Tıp Kitabevleri, Ankara, 2008, sf. 1321- 31. Ozalp S.S., Tanir M.H.: Gestational Trophoblastic Diseases, Text Book of Gynaecological Oncology, ed. Ayhan A., Gultekin M., Dursun P.,Turkish Society of Gynaecological Oncology (TSGO), European Society of Gynaecological Oncology (ESGO) and European Network of Young GYN Oncologists (ENYGO), Günefl Publishing, Ankara, 2009,
  3. Turkey, Bölüm 46, sf.225- 32. Pecorelli S, Ngan HYS, Hacker NF (eds.). Trophoblastic diseases. Staging Classifications and Clinical Practice Guidelines for Gynecological Cancers, A collaboration between FIGO and IGCS, third ed., 2006, sf. 122- 45. Tidy JA, Gillespie AM, Bright N, Radstone CR, Coleman RE, Hancock BW. Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol Oncol 2000; 78: 309- 12. Altıntafl A. Mol hidatidiformda tanı, yaklaflım ve profilaktik kemoterapi. Özalp S, ed. Gestasyonel Trofoblastik Hastalıklar. Eskiflehir: Anadolu Üniversitesi Basımevi, 1997; 119- 35. Özalp S, Hassa, H, fiener T, Minsin T. Elli dokuz mol hidatidiform olgusunun değerlendirilmesi. Jinekoloji ve Obstetrik Bülteni 1998; 7: 51- 6. Lurain JR.Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol. 2011; 204: 11- 8. Montz FJ, Schlaerth JB, Morrow The natural history of theca lutein cysts.Obstet Gynecol. Obstet Gynecol 1988; 72: 247- 51. Topuz S, Iyibozkurt C, Mete O, Akhan S, Salihoğlu Y, Bengisu E, Berkman S.Life-saving hysterectomy in choriocarcinoma: presentation of two cases. Eur J Gynaecol Oncol. 2008; 29: 664- 5. Tse KY, Chan KK, Tam KF, Ngan HY. 20-year experience of managing profuse bleeding in gestational trophoblastic disease. J Reprod Med. 2007; 52: 397- 401. Cagayan MS, Magallanes MS.The role of adjuvant surgery in the management of gestational trophoblastic neoplasia. J Reprod Med. 2008; 53: 513- 8. Curry SL, Hammond CB, Tyrey L, Creasman WT, Parker RT Hydatidiform mole: diagnosis, management, and long- term followup of 347 patients. Obstet Gynecol.1975; 45: 1- 8. Berkowitz RS, Goldstein DP. Gestat